A multicenter, randomized, phase III study of docetaxel plus best supportive care versus best supportive care in chemotherapy-naive patients with metastatic or non-resectable localized non-small cell lung cancer (NSCLC).
(Q53527972)
scientific article
scientific article
Language:
other details
description | scientific article |
External Links
(P356) |
10.1016/S0169-5002(00)00094-5
|
(P698) |
10699688
|
(P8608) |
release_zydo5grx2nc7xkrv5mwzxqkvtm
|